Findings from Stanford University School of Medicine Has Provided New Information about BCR-ABL Tyrosine Kinase Inhibitors (The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice)

Source :: Obesity, Fitness & Wellness Week. October 28, 2017, 571
Publication Year :: 2017
Abstract: 2017 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Drugs and Therapies - BCR-ABL Tyrosine Kinase [...]

Subjects :: Stanford University. School of Medicine
Drug therapy
Physical fitness
Imatinib mesylate
Tyrosine
Arthritis -- Drug therapy
Phenols (Class of compounds)
Purines

Tools